| Financial Year |
March 31 2023 |
| Monetary Funds |
2,075,224,297.60 |
| Held-for-trading Financial Assets |
125,630,000.00 |
| Notes Receivable |
4,736,216.12 |
| Accounts Receivable |
294,090,915.59 |
| Advances to Suppliers |
58,329,855.98 |
| Other Receivables |
2,900,421,797.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
13,728,840,778.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
248,325,711.50 |
| Total Current Assets |
19,438,718,720.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,561,089,962.45 |
| Investment Properties |
2,444,850,262.69 |
| Fixed Assetes |
480,560,206.62 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,336,102.27 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
298,588,158.75 |
| Deferred Income Tax Assets |
29,290,494.35 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
9,404,569,142.04 |
| Total Assets |
28,843,287,862.91 |
| Short-Term Loans |
199,224.05 |
| Trading Financial liabilities |
-- |
| Notes Payable |
303,065,438.21 |
| Accounts Payable |
1,463,573,222.61 |
| Accounts Received In Advance |
51,770,767.78 |
| Employee Compensation Payable |
9,295,790.16 |
| Taxes Payable |
-100,023,065.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,023,649,511.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,671,885,346.50 |
| Other Current Liabilities |
158,940,659.43 |
| Sub-Total of Current Liabilities |
19,371,396,400.63 |
| Long-term Loans |
3,320,690,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,549,216,805.07 |
| Total Liabilities |
24,920,613,205.70 |
| Paid-In Capital(Or Share Stock) |
1,734,215,770.00 |
| Capital Surplus |
1,297,748,821.04 |
| Surplus Reserve |
265,131,520.32 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,363,130,491.59 |
| Minority Stockholder's Interest |
1,988,709,037.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,933,965,619.77 |
| Owner's Equity（Stockholder's Equity） |
3,922,674,657.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
28,843,287,862.91 |
